Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol

Overview of attention for article published in BMC Cancer, February 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 24,003 followers.

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol. https://t.co/KvRZBt7mBI

21 Aug 2018

Reply Repost Favourite

RT @Myeloma_Doc: RT Transplant_Doc "Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vac…

24 Feb 2018

Reply Repost Favourite

RT @Myeloma_Doc: RT Transplant_Doc "Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vac…

20 Feb 2018

Reply Repost Favourite

RT Transplant_Doc "Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: stu... - PubMed - NCBI https://t.co/iZgfY7Ij56"

20 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.